Bruzzese L, Rostain J-C, Ne L, Condo J, Mottola G, Adjriou N, Mercier L, Berge-Lefranc J-L, Fromonot J, Kipson N, Lucciano M, Durand-Gorde J-M, Jammes Y, Guieu R, Ruf J, Fenouillet E
Current Neuropharmacology , 2017 Reviewed neuroprotective effects and modulation of dopaminergic and serotonergic pathways in preclinical models
Cell nuclei were labeled with DAPI and immunofluorescence analysis was performed under the confocal
Brain Structure Funct
Additionally, 38% of the analysis highlights innovation strategies, and 41% evaluates supply chain dynamics, providing data-driven insights into the Liraglutide and Semaglutide Market Outlook and future opportunities
In contrast, SGLT2 inhibitors have shown renal protective effects and may be prioritized in this group